You may have been shocked to learn you've got hepatitis C. Like a lot of folks, you might have thought you weren't at risk for the disease. It's normal to have lots of questions about what comes next. Find out how to get the support you need and where to turn for medical advice.
Hepatitis C treatments have changed a lot in recent years. One of the newer drugs is a once-daily pill called Harvoni that cures the disease in most people in 8-12 weeks. It combines two drugs: sofosbuvir (Sovaldi) and ledipasvir. In clinical trials, the most common side effects were fatigue and headache. The most recent drugs are ombitasvir-paritaprevir-dasabuvir-ritonavir (Viekira Pak), ombitasvir-paritaprevir-ritonavir (Technivie) and daclastasvir (Daklinza) which do not require interferon and cure more people in less time. Ombitasvir-paritaprevir-dasabuvir-ritonavir and ombitasvir-paritaprevir-ritonavir carry an FDA warning of severe liver injury if given to someone with underlying severe liver disease. All of these medicines are quite expensive.